Join
Live feed
·
PRReleasevia Quantisnow
Compass Therapeutics Inc. logo

Compass Therapeutics Provides Regulatory Update on Tovecimig in Biliary Tract Cancer Following FDA Feedback

ByQuantisnow·Wall Street's wire, on your screen.
CMPX· Compass Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CMPX (Compass Therapeutics Inc.) and more on Quantisnow.